期刊文献+
共找到13篇文章
< 1 >
每页显示 20 50 100
External validation of the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer colorectal(CR29)module:Monocentric study
1
作者 Houda Bachri Hajar Essangri +4 位作者 Nezha El Bahaoui Amine Benkabbou Raouf Mohsine Anass Mohammed Majbar Amine Souadka 《World Journal of Methodology》 2023年第4期259-271,共13页
BACKGROUND Quality of life(QoL)outcomes are a focal endpoint of cancer treatment strategies.AIM To externally validate the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer(EORT... BACKGROUND Quality of life(QoL)outcomes are a focal endpoint of cancer treatment strategies.AIM To externally validate the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer(EORTC)QoL Questionnaire(QLQ)for colorectal cancer(CRC)patients(CR29).METHODS Both Moroccan Arabic modules of QLQ-CR29 and QLQ-C30 were administered to Moroccan CRC.Psychometric properties were retested by measuring Cronbach’s alpha coefficient for reliability and Intraclass correlation coefficient(ICC)to examine test-retest reproducibility.The multitrait-scaling analysis was performed to demonstrate the validity of the instrument and known-groups comparison was used to test the score’s ability to discriminate between different groups of patients.RESULTS In total,221 patients were included in our study and 34 patients completed the questionnaire twice.The Urinary Frequency scale and Stool Frequency scale had good internal consistency with alpha Cronbach coefficients of 0.79 and 0.83 respectively,while the same coefficients were moderately lower for the Blood and Mucus in Stool scale(0.61)and the Body Image scale(0.67).The ICCs ranged from 0.88 to 1 indicating good to excellent reproducibility.In multitrait scaling analyses,the criterion for item convergent and divergent validity was satisfactory.The known-group comparison showed statistically significant differences between patients according to age,gender,stoma status,tumor location,and radiotherapy.CONCLUSION The Moroccan Arabic version of the EORTC QLQ-CR29 is a valid and reliable tool that can be used safely for research and clinical purposes in Moroccan CRC patients. 展开更多
关键词 Rectal neoplasm Colorectal cancer Health-related quality of life Patient reported outcome measures european organization for research and treatment of cancer quality of life Questionnaire-CR29 european organization for research and treatment of cancer quality of life Questionnaire-c30
下载PDF
Quality of life after laparoscopic vs open sphincter-preserving resection for rectal cancer 被引量:6
2
作者 Simon Siu-Man Ng Wing-Wa Leung +4 位作者 Cherry Yee-Ni Wong Sophie Sok-Fei Hon Tony Wing-Chung Mak Dennis KwokYu Ngo Janet Fung-Yee Lee 《World Journal of Gastroenterology》 SCIE CAS 2013年第29期4764-4773,共10页
AIM: To compare quality of life (QoL) outcomes in Chinese patients after curative laparoscopic vs open surgery for rectal cancer. METHODS: Eligible Chinese patients with rectal cancer undergoing curative laparoscopic ... AIM: To compare quality of life (QoL) outcomes in Chinese patients after curative laparoscopic vs open surgery for rectal cancer. METHODS: Eligible Chinese patients with rectal cancer undergoing curative laparoscopic or open sphincterpreserving resection between July 2006 and July 2008 were enrolled in this prospective study. The QoL outcomes were assessed longitudinally using the validated Chinese versions of the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQCR38 questionnaires before surgery and at 4, 8, and 12 mo after surgery. The QoL scores at the different time points were compared between the laparoscopic and open groups. A higher score on a functional scale indicated better functioning, whereas a higher score on a symptom scale indicated a higher degree of symptoms.RESULTS: Seventy-four patients (49 laparoscopic and 25 open) were enrolled. The two groups of patients were comparable in terms of sociodemographic data, types of surgery, tumor staging, and baseline mean QoL scores. There was no significant decrease from baseline in global QoL for the laparoscopic group at different time points, whereas the global QoL was worse compared to baseline beginning at 4 mo but returned to baseline by 12 mo for the open group (P = 0.019, Friedman test). Compared to the open group, the laparoscopic group had significantly better physical (89.9±1.4 vs 79.2±3.7, P = 0.016), role (85.0±3.4 vs 63.3±6.9, P = 0.005), and cognitive (73.5±3.4 vs 50.7±6.2, P = 0.002) functioning at 8 mo, fewer micturition problems at 4-8 mo (4 mo: 32.3±4.7 vs 54.7±7.1, P = 0.011; 8 mo: 22.8±4.0 vs 40.7±6.9, P = 0.020), and fewer male sexual problems from 8 mo onward (20.0±8.5 vs 76.7±14.5, P = 0.013). At 12 mo after surgery, no significant differences were observed in any functional or symptom scale between the two groups, with the exception of male sexual problems, which remained worse in the open group (29.2±11.3 vs 80.0±9.7, P = 0.026). CONCLUSION: Laparoscopic sphincter-preserving resection for rectal cancer is associated with better preservation of QoL and fewer male sexual problems when compared with open surgery in Chinese patients. These findings, however, should be interpreted with caution because of the small sample size of the study. 展开更多
关键词 quality of life Rectal cancer LAPAROSCOPIC SURGERY Sphincter-preserving SURGERY european organization for research and treatment of cancer QLQ-c30 european organization for research and treatment of cancer QLQ-CR38
下载PDF
Systematic review of health-related quality of life after esophagectomy for esophageal cancer 被引量:15
3
作者 Marco Scarpa Stefano Valente +4 位作者 Rita Alfieri Matteo Cagol Giorgio Diamantis Ermanno Ancona Carlo Castoro 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第42期4660-4674,共15页
This study is aimed to assess the long-term health-related quality of life(HRQL) of patients after esopha-gectomy for esophageal cancer in comparison with es-tablished norms,and to evaluate changes in HRQL during the ... This study is aimed to assess the long-term health-related quality of life(HRQL) of patients after esopha-gectomy for esophageal cancer in comparison with es-tablished norms,and to evaluate changes in HRQL during the different stages of follow-up after esopha-geal resection. A systematic review was performed bysearching medical databases(Medline,Embase andthe Cochrane Library) for potentially relevant studiesthat appeared between January 1975 and March 2011.Studies were included if they addressed the questionof HRQL after esophageal resection for esophage alcancer. Two researchers independently performed the study selection,data extraction and analysis processes.Twenty-one observational studies were included witha total of 1282(12-355) patients. Five studies were performed with short form-36(SF-36) and 16 with European Organization for Research and Treatment of Cancer(EORTC) QLQ C30(14 of them also utilized the disease-specific OES18 or its previous version OES24) .The analysis of long-term generic HRQL with SF-36showed pooled scores for physical,role and socialfunction after esophagectomy similar to United Statesnorms,but lower pooled scores for physical function,vitality and general health perception. The analysis of HRQL conducted using the Global EORTC C30 globalscale during a 6-mo follow-up showed that global scaleand physical function were better at the baseline. The symptom scales indicated worsened fatigue,dyspneaand diarrhea 6 mo after esophagectomy. In contrast,however,emotional function had significantly improved after 6 mo. In conclusion,short- and long-term HRQLis deeply affected after esophagectomy for cancer. The impairment of physical function may be a long-termconsequence of esophagectomy involving either the respiratory system or the alimentary tract. The short-and long-term improvement in the emotional function of patients who have undergone successful operationsmay be attributed to the impression that they have survived a near-death experience. 展开更多
关键词 呼吸系统 食管癌 生活质量 健康 MEDLINE 生理功能 全球范围 数据提取
下载PDF
Value of quality of life analysis in liver cancer: A clinician's perspective 被引量:11
4
作者 Leung Li Winnie Yeo 《World Journal of Hepatology》 CAS 2017年第20期867-883,共17页
Health related quality of life(HRQOL) is increasingly recognized as an important clinical parameter and research endpoint in patients with hepatocellular carcinoma(HCC). HRQOL in HCC patients is multifaceted and affec... Health related quality of life(HRQOL) is increasingly recognized as an important clinical parameter and research endpoint in patients with hepatocellular carcinoma(HCC). HRQOL in HCC patients is multifaceted and affected by medical factor which encompasses HCC and its complications, oncological and palliative treatment for HCC, underlying liver disease, as well as the psychological, social or spiritual reaction to the disease. Many patients presented late with advanced disease and limited survival, plagued with multiple symptoms, rendering QOL a very important aspect in their general well being. Various instruments have been developed and validated to measure and report HRQOL in HCC patients, these included general HRQOL instruments, e.g., Short form(SF)-36, SF-12, Euro Qo L-5D, World Health Organization Quality of Life Assessment 100(WHOQOL-100), World Health Organization Quality of Life Assessment abbreviated version; general cancer HRQOL instruments, e.g., the European Organisation for Research and Treatment of Cancer(EORTC) QLQ-C30, Functional Assessment of Cancer Therapy(FACT)-General, Spitzer Quality of Life Index; and liver-cancer specific HRQOL instruments, e.g., EORTC QLQ-HCC18, FACT-Hepatobiliary(FACT-Hep), FACT-Hep Symptom Index, Trial Outcome Index. Important utilization of HRQOL in HCC patients included description of symptomatology and HRQOL of patients, treatment endpoint in clinical trial, prognostication of survival, benchmarking of palliative care service and health care valuation. In this review, difficulties regarding the use of HRQOL data in research and clinical practice, including choosing a suitable instrument, problems of missing data, data interpretation, analysis and presentation are examined. Potential solutions are also discussed. 展开更多
关键词 Hepatocellular carcinoma Health related quality of life Palliative care Prognosis Survival The european Organisation for research and treatment of cancer QLQ-c30 QLQ-HCC18 Index score Functional Assessment of cancer Therapy EQ-5D SPITZER Short form 36 FHSI-8 World Health organization quality of life Assessment
下载PDF
Development of Improved Version of Quality of Life Assessment Instrument for Lung Cancer Patients Based on Traditional Chinese Medicine(QLASTCM-Lu) 被引量:2
5
作者 WANG Ting-ting HE Li-yun +6 位作者 ZHANG Ming WANG Shao-mo ZHAO Ai-guang CHU Lei ZHANG Li-yuan YOU Sheng-fu YOU Jie 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2019年第11期831-836,共6页
Objective: To develop an improved version of the Quality-of-Life Assessment instrument for Lung Cancer Patients Based on Traditional Chinese Medicine (QLASTCM-Lu) and to evaluate its psychometric property. Methods: Th... Objective: To develop an improved version of the Quality-of-Life Assessment instrument for Lung Cancer Patients Based on Traditional Chinese Medicine (QLASTCM-Lu) and to evaluate its psychometric property. Methods: The structured group method and the theory in developing rating scale were employed to revise the preliminary scale. The psychometric property (reliability, validity, and responsiveness) of the established QLASTCM-Lu (modified) were evaluated by quality of life data measured in 100 lung cancer patients. Statistical analyses were made accordingly by way of correlation analysis, factor analysis and paired t-test. Results: The internal consistency reliability of the overall scale and all domains was from 0.80 to 0.94. Correlation and factor analyses demonstrated that the scale was good in construct validity. The criterion validity was formed with European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire- Lung Cancer (EORTC QLQ-LC43) as the criterion. Statistically significant changes were found apart from such domain as "mental condition" and "social function", with the standardized response means being close to those of QLQ-LC43. Conclusion: QLASTCM-Lu (modified) could be used to measure the quality of life of lung cancer patients with good reliability, validity and a certain degree of responsiveness. 展开更多
关键词 LUNG cancer quality of life Chinese MEDICINE scale european organization for research and treatment of cancer
原文传递
胃大部切除术后3年胃癌患者生活质量的EORTC QLQ-C30与QLQ-STO22联合评价 被引量:30
6
作者 周燕燕 席淑华 《世界华人消化杂志》 CAS 北大核心 2012年第19期1782-1786,共5页
目的:采用欧洲癌症研究与治疗组织(EORTC)生活质量核心30问卷调查(QLQ-C30)和QLQ-STO22评价胃癌术后3年患者的生活质量(QOL).方法:对96名胃大部切除术后3年的胃癌患者和90名年龄和性别相匹配的门诊体检健康者进行研究.胃癌患者和健康者... 目的:采用欧洲癌症研究与治疗组织(EORTC)生活质量核心30问卷调查(QLQ-C30)和QLQ-STO22评价胃癌术后3年患者的生活质量(QOL).方法:对96名胃大部切除术后3年的胃癌患者和90名年龄和性别相匹配的门诊体检健康者进行研究.胃癌患者和健康者平均年龄分别为53.2岁±8.1岁和54.8岁±7.9岁.88.5%患者为I期胃癌术后.患者自行完成QLQ-C30量表和QLQ-STO22量表,对各评分进行统计分析.结果:胃癌患者和健康者EORTC QLQ-C30整体健康状况和QOL评分无显著差异.胃癌患者的认知功能、情绪功能和疲劳要优于对照健康者.但胃癌患者恶心和呕吐评分、经济困难、反流、进食受限和体型评分较健康者差.其他评分未见显著差异.结论:胃癌术后3年,患者的QOL整体评分基本恢复至正常水平,但在某些方面,特别是与上消化道相关的症状(如恶心呕吐、反流、进食受限等)与健康者存在差距.有必要基于这些差异采取针对性的措施进行治疗和护理. 展开更多
关键词 胃癌 生活质量 EORTC QLQ-c30 QLQ-STO22
下载PDF
复方守宫散辅助治疗晚期结直肠恶性肿瘤的疗效观察
7
作者 马佳 孙叶晗 +1 位作者 陈友谋 祝永福 《安徽中医药大学学报》 CAS 2024年第1期21-26,共6页
目的基于倾向性评分匹配法探讨复方守宫散辅助治疗晚期结直肠恶性肿瘤的疗效。方法采用倾向性评分匹配法,将匹配成功的70例患者分为对照组(化学治疗)和观察组(复方守宫散联合化学治疗),每组35例;比较两组患者瘤体客观疗效[客观缓解率(ob... 目的基于倾向性评分匹配法探讨复方守宫散辅助治疗晚期结直肠恶性肿瘤的疗效。方法采用倾向性评分匹配法,将匹配成功的70例患者分为对照组(化学治疗)和观察组(复方守宫散联合化学治疗),每组35例;比较两组患者瘤体客观疗效[客观缓解率(objective response rate,ORR),疾病控制率(disease control rate,DCR)]、生活质量评分、免疫功能指标、安全性指标,并对生存期进行分析。结果观察组ORR、DCR优于对照组(P<0.05);观察组患者治疗后功能维度(躯体功能、角色功能、情绪功能、认知功能、社会功能),症状领域(疲劳、疼痛、恶心呕吐)评分改善程度显著优于对照组(P<0.05);观察组患者血清CD4+T细胞、CD8+T细胞、自然杀伤细胞水平,CD4+/CD8+均显著高于对照组(P<0.05);治疗组患者总不良反应发生率显著低于对照组(P<0.05);观察组的中位无进展生存期显著高于对照组(P<0.05),中位总生存期高于对照组(P>0.05)。结论相较于单纯化学治疗,复方守宫散与化学治疗联合应用能显著提高疗效,增强机体免疫力,改善晚期结直肠癌患者生活质量,降低化学治疗的毒性及不良反应,在一定程度上延长患者生存时间。 展开更多
关键词 复方守宫散 倾向评分匹配 晚期结直肠癌 欧洲癌症研究组生命质量测定量表
下载PDF
电针缓解癌痛患者阿片耐受的临床观察
8
作者 李莎 田伟千 +4 位作者 赵峰 季淑娟 姚凤珍 汤洋 朱明慧 《上海针灸杂志》 CSCD 2023年第9期889-894,共6页
目的观察电针缓解癌痛患者阿片耐受的临床疗效。方法将60例癌痛患者随机分为电针组和对照组,每组30例。两组均使用阿片类药物进行镇痛治疗,电针组取双侧内关和足三里穴进行电针治疗,对照组取双侧内关和足三里穴旁开15 mm处非穴位点进行... 目的观察电针缓解癌痛患者阿片耐受的临床疗效。方法将60例癌痛患者随机分为电针组和对照组,每组30例。两组均使用阿片类药物进行镇痛治疗,电针组取双侧内关和足三里穴进行电针治疗,对照组取双侧内关和足三里穴旁开15 mm处非穴位点进行电针治疗。观察两组阿片耐受指数、爆发痛的次数和疼痛缓解持续时间,比较两组治疗前后数字等级评定量表(numeric rating scale,NRS)和欧洲癌症研究与治疗组织生命质量核心量表(European Organization for Research and Treatment of Cancer quality of life questionnaire-C30,EORTC QLQ-C30)评分变化,并比较两组不良反应发生率。结果电针组阿片耐受指数低于对照组(P<0.05),爆发痛次数低于对照组(P<0.05),疼痛缓解持续时间长于对照组(P<0.05)。电针组治疗后情绪、躯体、认知和社会功能及总体健康评分高于治疗前和对照组(P<0.05);电针组治疗后疲倦、恶心呕吐、疼痛、气促、失眠、食欲丧失和便秘评分低于治疗前和对照组(P<0.05)。电针组恶心呕吐和便秘的发生率低于对照组(P<0.05)。结论电针可减少癌痛患者镇痛治疗期间阿片耐受的发生,减轻疼痛,提高生活质量。 展开更多
关键词 电针 针药并用 癌痛 药物耐受 内关 足三里 数字等级评定量表 欧洲癌症研究与治疗组织生命质量核心量表
下载PDF
升降汤加减治疗食管癌术后胃肠功能紊乱临床研究 被引量:8
9
作者 樵小健 缑一杰 +4 位作者 李刚 李宏 姚树雄 马贵能 刘伟 《新中医》 CAS 2020年第5期37-39,共3页
目的:观察升降汤加减治疗食管癌术后胃肠功能紊乱的临床效果。方法:选取160例食管癌术后胃肠功能紊乱患者,按随机数字表法分为治疗组和对照组各80例。2组患者术后给予常规治疗及对症处理,对照组给予多潘立酮片口服,治疗组在对照组基础... 目的:观察升降汤加减治疗食管癌术后胃肠功能紊乱的临床效果。方法:选取160例食管癌术后胃肠功能紊乱患者,按随机数字表法分为治疗组和对照组各80例。2组患者术后给予常规治疗及对症处理,对照组给予多潘立酮片口服,治疗组在对照组基础上加用升降汤加减治疗。观察2组临床疗效及症状评分变化,采用癌症患者生活质量测定量表(EORTC QLQ-C30)评估患者生活质量。结果:治疗组总有效率为93.75%,高于对照组61.67%(P<0.05)。治疗前,2组腹痛、恶心呕吐、上腹胀、伴随症状评分比较,差异无统计学意义(P>0.05)。治疗后,2组腹痛、恶心呕吐、上腹胀、伴随症状评分较治疗前降低(P<0.05),且治疗组腹痛、恶心呕吐、上腹胀、伴随症状评分低于对照组(P<0.05)。治疗前,2组生活质量各项评分比较,差异无统计学意义(P>0.05)。治疗后,2组生活质量各项评分较治疗前升高(P<0.05),且治疗组生活质量各项评分高于对照组(P<0.05)。结论:升降汤加减治疗食管癌术后胃肠功能紊乱,可显著改善患者相关临床症状,患者术后生活质量得到改善,总体预后效果较好。 展开更多
关键词 食管癌 手术 胃肠功能紊乱 升降汤 临床症状 癌症患者生活质量测定量表(EORTC QLQ-c30)
下载PDF
73例生存期3年以上急性白血病患者生活质量及影响因素分析 被引量:4
10
作者 张俊平 曾顺菲 +3 位作者 刘艳霞 王志新 刘美晶 赵岳 《天津护理》 2018年第2期161-165,共5页
目的:探讨生存期3年以上急性白血病患者生活质量及其影响因素。方法:采用一般状况调查问卷、癌症患者生活质量测定量表(European Organization for Research and Treatment of Cancer,EORTC QLQ-C30)中文版、体能状况评估表(ECOG)对73... 目的:探讨生存期3年以上急性白血病患者生活质量及其影响因素。方法:采用一般状况调查问卷、癌症患者生活质量测定量表(European Organization for Research and Treatment of Cancer,EORTC QLQ-C30)中文版、体能状况评估表(ECOG)对73例生存期3年以上急性白血病患者进行问卷调查。结果:生存期3年以上急性白血病患者生活质量总分为(82.2±20.7)分,其中躯体功能得分最高,社会功能得分最低。在症状维度中,恶心呕吐症状最轻微,经济困难情况最严重。影响急性白血病患者生活质量总健康状况的因素为:体能状况、是否恢复工作。结论:生存期3年以上急性白血病患者生活质量得到改善,癌症相关症状得到控制。可根据患者体能状况及恢复工作情况给与康复指导,提高其生活质量。 展开更多
关键词 急性白血病 生存期 生活质量 EORTCQLQ-c30
下载PDF
补脾益气黄芪粥对肺癌化疗癌因性疲乏患者生活质量的影响 被引量:4
11
作者 李月 王芳 +3 位作者 易静 钟秋润 简凤 廖顺琪 《新中医》 CAS 2021年第24期165-169,共5页
目的:观察补脾益气黄芪粥对晚期肺脾气虚型非小细胞肺癌(NSCLC)化疗伴癌因性疲乏(CRF)患者生活质量的影响。方法:将70例符合纳入标准的晚期肺脾气虚型NSCLC化疗伴CRF患者,随机分为2组各35例。对照组接受常规治疗和护理,观察组在对照组... 目的:观察补脾益气黄芪粥对晚期肺脾气虚型非小细胞肺癌(NSCLC)化疗伴癌因性疲乏(CRF)患者生活质量的影响。方法:将70例符合纳入标准的晚期肺脾气虚型NSCLC化疗伴CRF患者,随机分为2组各35例。对照组接受常规治疗和护理,观察组在对照组基础上应用补脾益气黄芪粥。比较干预前后2组患者医院焦虑抑郁量表(HADS)、匹兹堡睡眠质量指数表(PSQI)和肺癌患者生活质量核心量表(EORTC QLQ-C30)的评分。结果:干预后,观察组HADS评分、PSQI各部分评分及总评分,EORTC QLQ-C30中躯体、角色和情绪功能以及疲倦、疼痛、气促、失眠等症状评分均低于对照组(P<0.05);2组认知功能、社会功能以及总体健康状况评分比较,差异均无统计学意义(P>0.05)。结论:补脾益气黄芪粥可减轻晚期NSCLC化疗伴CRF患者负性情绪,改善睡眠质量,提高患者生活质量。 展开更多
关键词 癌因性疲乏 非小细胞肺癌 肺脾气虚证 补脾益气 补脾益气黄芪粥 医院焦虑抑郁量表 匹兹堡睡眠质量指数表 肺癌患者生活质量核心量表
下载PDF
探讨预见性护理干预在肝胆管结石围手术期的应用效果 被引量:1
12
作者 张凯丽 《临床研究》 2022年第9期153-155,共3页
目的探讨预见性护理干预在肝胆管结石围手术期的应用效果。方法回顾性分析2018年3月至2020年4月在河南省人民医院进行肝胆管结石手术的72例患者临床手术资料。将36例接受常规护理的患者纳入对照组,将围手术期内接受预见性护理的36例患... 目的探讨预见性护理干预在肝胆管结石围手术期的应用效果。方法回顾性分析2018年3月至2020年4月在河南省人民医院进行肝胆管结石手术的72例患者临床手术资料。将36例接受常规护理的患者纳入对照组,将围手术期内接受预见性护理的36例患者纳入观察组,比较两组营养状况改善情况[前白蛋白(PAB)、白蛋白(ALB)水平]、负性情绪改善情况[汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表17项版(HAMD-17)得分]、生活质量改善情况[欧洲癌症研究与治疗组织生活质量核心问卷(EORTC QLQ C30)评分]及并发症(切口开裂或感染、胸腔积液、肠梗阻、胆漏)的发生情况。结果干预后,观察组PAB、ALB水平均高于常规组,差异有统计学意义(P<0.05);观察组HAMA及HAMD-17得分均低于常规组,差异有统计学意义(P<0.05);观察组EORTC QLQ C30中躯体功能、角色功能、认知功能、情绪功能及社会功能评分均高于常规组,差异有统计学意义(P<0.05);观察组并发症发生率为2.78%,低于常规组的16.67%,差异有统计学意义(P<0.05)。结论于肝胆管结石患者围手术期内采取预见性护理措施,可改善其肝功能及营养状况,减轻负性情绪对其身心状态的影响,减少胆漏、切口感染等不良反应的发生,促进其生活质量获得显著提升。 展开更多
关键词 预见性护理 肝胆管结石 前白蛋白 欧洲癌症研究与治疗组织生活质量核心问卷
下载PDF
参莲抗癌合剂联合化疗治疗结肠癌晚期患者临床研究
13
作者 杨芳 《新中医》 CAS 2019年第8期197-201,共5页
目的:观察参莲抗癌合剂联合化疗对结肠癌晚期患者的临床效果,探讨其可能的作用机制。方法:选取104例晚期结肠癌患者作为研究对象,按照随机数字表法分为对照组和观察组各52例。对照组给予FOLFIRI方案化疗,观察组则在对照组基础上加用自... 目的:观察参莲抗癌合剂联合化疗对结肠癌晚期患者的临床效果,探讨其可能的作用机制。方法:选取104例晚期结肠癌患者作为研究对象,按照随机数字表法分为对照组和观察组各52例。对照组给予FOLFIRI方案化疗,观察组则在对照组基础上加用自拟参莲抗癌合剂内服治疗,2周为1个疗程,连续治疗4个疗程。观察2组患者的近期临床疗效,治疗前后检测免疫功能相关指标T淋巴细胞亚群、免疫球蛋白水平,采用欧洲癌症研究治疗组织的生命质量核心问卷(EORTC QLQ-C30)评价生活质量,监测血清白细胞介素-17 (IL-17)、低氧诱导因子-1α(HIF-1α)、血管内皮生长因子(VEGF)水平,记录2组患者的不良反应。结果:观察组的近期疗效总有效率为51.92%,高于对照组的28.85%,差异有统计学意义(χ~2=7.329,P <0.05)。治疗后,2组T淋巴细胞群指标CD4^+、CD4^+/CD8^+及免疫球蛋白IgA、IgG、IgM水平较治疗前明显升高,且观察组各项指标均高于对照组,差异均有统计学意义(P <0.05);CD8^+水平较治疗前明显降低,且观察组低于对照组,差异有统计学意义(P <0.05)。治疗后,2组症状量表评分较治疗前明显降低,功能量表评分较治疗前明显升高;且观察组症状量表评分低于对照组,功能量表评分高于对照组;差异均有统计学意义(P <0.05)。治疗后,2组血清IL-17、HIF-1α、VEGF水平较治疗前降低,且观察组各项指标均低于对照组,差异均有统计学意义(P <0.05)。观察组白细胞减少、贫血、血小板减少、恶心呕吐、口腔溃疡、肝功能异常、神经毒性等不良反应的发生率明显低于对照组(P <0.05)。结论:参莲抗癌合剂联合化疗能明显提高患者的机体免疫功能及生活质量,减毒增效作用突出,其机制可能与通过降低血清IL-17、HIF-1α、VEGF水平而抑制炎症反应、抑制肿瘤血管增殖有关,有一定的临床推广运用价值。 展开更多
关键词 结肠癌 参莲抗癌合剂 化疗 T淋巴细胞亚群 免疫球蛋白 欧洲癌症研究治疗组织的生命质量核心问卷(EORTC QLQ-c30) 低氧诱导因子-1α(HIF-1α) 血管内皮生长因子(VEGF)
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部